BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24485294)

  • 1. [Incidence and mortality of urological cancers in 2012 in France].
    Rébillard X; Grosclaude P; Leone N; Velten M; Coureau G; Villers A; Irani J; Lebret T; Rigaud J; Pfister C; Patard JJ; Richaud P; Salomon L; Coloby P; Soulié M;
    Prog Urol; 2013 Nov; 23 Suppl 2():S57-65. PubMed ID: 24485294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing occurrence of urological cancers in Slovakia.
    Plesko I; Obsitnikova A; Cuninkova M; Tomasek L; Stefanakova D; Kubik A
    Neoplasma; 2004; 51(4):248-54. PubMed ID: 15254654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Descriptive epidemiology of urologic cancers].
    Schaffer P; Lavillaureix P; Bollack C
    J Urol (Paris); 1984; 90(7):475-82. PubMed ID: 6530561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of urogenital cancers in France].
    Rébillard X; Tretarre B;
    Rev Prat; 2007 Mar; 57(6):595-602. PubMed ID: 17593783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urologic cancer at the Hérault department: 14 years of continuous registration].
    Tretarre B; Rebillard X; Daures JP; Iborra F; Arcou ; Crisap-Lr
    Prog Urol; 2003 Jun; 13(3):394-403. PubMed ID: 12940191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence and mortality of prostate cancer in France: trends between 1978 and 2000].
    Bauvin E; Remontet L; Grosclaude P; ;
    Prog Urol; 2003 Dec; 13(6):1334-9. PubMed ID: 15000309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Projected incidence and mortality from urologic cancer in France in 2010.].
    Rébillard X; Grosclaude P; Lebret T; Patard JJ; Pfister C; Richaud P; Rigaud J; Salomon L; Soulié M
    Prog Urol; 2010 Nov; 20 Suppl 4():S211-4. PubMed ID: 21129643
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urologic cancer mortality in France].
    Rezvani A
    Ann Urol (Paris); 1992; 26(5):266-74. PubMed ID: 1485795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality.
    Greiman AK; Rosoff JS; Prasad SM
    BJU Int; 2017 Dec; 120(6):799-807. PubMed ID: 28480994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea.
    Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
    Cancer Res Treat; 2017 Jul; 49(3):607-615. PubMed ID: 27658388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evolution of the number of incident cases of prostate cancer in France from 2001 to 2012 from 5 hospital centers].
    Helfrich O; Crouzet S; Ruffion A; Houlgatte A; Cavillon C; Gerard C; Villers A
    Prog Urol; 2015 Mar; 25(3):147-56. PubMed ID: 25481672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
    Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
    Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of incidence of urological cancer in South Korea: a 15-year summary.
    Cheon J; Kim CS; Lee ES; Hong SJ; Cho YH; Shin EC; Lee WC; Yoon MS
    Int J Urol; 2002 Aug; 9(8):445-54. PubMed ID: 12225342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The frequency of cancer in France in 2006, mortality trends since 1950, incidence trends since 1980 and analysis of the discrepancies between these trends].
    Guérin S; Doyon F; Hill C
    Bull Cancer; 2009 Jan; 96(1):51-7. PubMed ID: 19211360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune disease and subsequent urological cancer.
    Liu X; Ji J; Forsti A; Sundquist K; Sundquist J; Hemminki K
    J Urol; 2013 Jun; 189(6):2262-8. PubMed ID: 23228387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
    Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
    Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gout patients have an increased risk of developing most cancers, especially urological cancers.
    Chen CJ; Yen JH; Chang SJ
    Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Burden of Urologic Cancers, 1990-2013.
    Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
    Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of prostate and urological cancers in England by ethnic group, 2001-2007: a descriptive study.
    Maruthappu M; Barnes I; Sayeed S; Ali R
    BMC Cancer; 2015 Oct; 15():753. PubMed ID: 26486598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in the incidences of the most prevalent urologic cancers from 2003 to 2009 in Iran.
    Basiri A; Shakhssalim N; Jalaly NY; Miri HH; Partovipour E; Panahi MH
    Asian Pac J Cancer Prev; 2014; 15(3):1459-63. PubMed ID: 24606483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.